Disseminated Intravascular Coagulation Nursing Care Plans

DIC kills fast. The clotting cascade fires out of control, throwing microthrombi that starve organs while the body burns through platelets and clotting factors until the patient bleeds from everywhere at once. You will see thrombosis and hemorrhage happening together, and that paradox is the whole problem. Your job is to catch it early, support the failing organs, stop the bleeding, and buy time while the team treats whatever set it off.

What is Disseminated Intravascular Coagulation?

Disseminated intravascular coagulation (DIC) is a coagulation disorder that overstimulates the normal clotting cascade, producing simultaneous thrombosis and hemorrhage. Microclots block perfusion to major organs, causing hypoxia, ischemia, and tissue damage. Clotting runs through two pathways: the intrinsic pathway, triggered by endothelial damage (commonly from sepsis or infection), and the extrinsic pathway, triggered by tissue injury (malignancy, trauma, or obstetrical complications). DIC can be acute or chronic.

Medical management targets the underlying cause, supports organ function, halts the abnormal coagulation, and controls bleeding. Morbidity and mortality track with the cause and the severity of the coagulopathy.

Nursing Care Plans and Management

Care centers on monitoring vital signs and bleeding, giving fluids and blood products, running bleeding precautions, wound care, respiratory support, and psychosocial support.

Nursing Priorities

1. Minimize bleeding risk
2. Support respiration
3. Educate the patient

Nursing Assessment

Assess for the following subjective and objective data:

• Abnormal arterial blood gases (ABGs)
• Abnormal breathing (rate, depth, rhythm)
• Confusion
• Dyspnea
• Hypercapnia
• Hypoxemia and hypoxia
• Irritability and restlessness
• Somnolence
• Abnormal blood profile
• Capillary refill >3 seconds
• Changes in level of consciousness
• Chest pain
• Cyanosis
• Hematuria
• Oliguria

Assess for factors related to the cause:

• Altered oxygen-carrying capacity of the blood
• Disrupted blood circulation and microthrombi
• Depleted coagulation factors
• Adverse effects of heparin therapy
• Complexity of treatment and a new, unfamiliar condition

Nursing Goals

• The client maintains optimal gas exchange: ABGs in the usual range, oxygen saturation of 90% or greater, alert and responsive mentation or no further drop in level of consciousness, and relaxed breathing at baseline heart rate.
• The client maintains peripheral tissue perfusion in the affected extremity: strong palpable pulses, reduced or absent pain, warm and dry extremities, and adequate capillary refill.
• The client has fewer episodes of bleeding and hematomas.
• The client has fewer side effects from medication therapy.
• The client maintains therapeutic coagulation values (prothrombin time, partial thromboplastin time, fibrinogen, fibrin split products, and bleeding time).
• The client and family verbalize a basic understanding of the condition, risk factors, and treatment.

Nursing Interventions and Actions

1. Promoting Effective Gas Exchange

Microclots and bleeding both hit the lungs, so oxygenation is a moving target. Watch oxygen saturation and ABGs closely, support ventilation with positioning and supplemental oxygen, and keep treating the underlying cause.

1. Assess for changes in level of consciousness. Restlessness and irritability are early signs of cerebral hypoxia. Confusion and somnolence come later.

2. Assess respiratory depth, rate, and rhythm. Breathing patterns shift over time to compensate. Rapid, shallow respirations point to hypoxia or to acidosis with shock. Hypoventilation means the patient needs ventilator support now.

3. Assess breath sounds and check the cough for bloody sputum. Changes in breath sounds can reveal the cause of impaired gas exchange. Hemoptysis signals bleeding in the respiratory tract.

4. Assess for tachycardia, shortness of breath, and accessory muscle use. These mark increased work of breathing. Heart rate rises with early hypoxia, and accessory muscles recruit to move more air.

5. Monitor oxygen saturation and ABGs. Pulse oximetry catches early drops in saturation; keep it at 90% or greater. Rising PaCO2 and falling PaO2 signal hypoxemia and respiratory acidosis.

6. Stay with the client during acute respiratory distress. Anxiety drives up dyspnea, work of breathing, and respiratory rate.

7. Reposition every 2 hours and perform chest physiotherapy. This moves and drains secretions.

8. Position in high-Fowler's as indicated. Upright positioning opens up diaphragmatic and lung excursion for better expansion.

9. Assist with coughing or suction as needed. Productive coughing clears moist secretions best. Suction when the client cannot clear them independently.

10. Maintain the ordered oxygen delivery device. Continuous delivery holds saturation at 90% or greater.

11. Anticipate intubation and mechanical ventilation. Early intubation heads off full decompensation and maintains oxygenation and ventilation.

2. Enhancing Tissue Perfusion

Microthrombi cut off oxygen and nutrients to organs, and the consumed platelets and clotting factors set up bleeding. Track blood pressure, heart rate, and urine output to read perfusion, and support volume and pressure while the team treats the cause.

1. Assess for contributing factors. DIC starts when the clotting proteins become overactive. Infection, severe trauma, inflammation, surgery, obstetrical complications (abruptio placentae, intrauterine fetal death), and cancer all contribute.

2. Assess for signs and symptoms of DIC. Bleeding from mucous membranes, venipuncture sites, and the GI and urinary tracts.

3. Assess for chest pain and shortness of breath. Clots in the pulmonary and coronary vessels block flow and produce these symptoms.

4. Assess urine amount and color. Hematuria and oliguria (output less than 30 mL/hour) follow decreased renal perfusion from tissue injury and clotted capillary beds.

5. Assess level of consciousness. A decreased level of consciousness can come from hemorrhagic changes or poor cerebral oxygenation.

6. Assess ABGs. ABGs may show compensatory respiratory alkalosis as the body tries to offload hydrogen ions generated by tissue-level hypoxia.

7. Monitor platelet count. Thrombocytopenia drives abnormal bleeding, from either reduced marrow production or increased platelet destruction.

8. Monitor PT and PTT. Both prolong as coagulation factors are consumed.

9. Monitor D-dimer. D-dimer detects a protein released during clot breakdown and runs markedly elevated in DIC.

10. Position in semi-Fowler's to high-Fowler's as tolerated. Upright positioning improves alveolar gas exchange.

11. Provide oxygen therapy as needed. This saturates circulating hemoglobin and gets more oxygen to ischemic tissue.

12. Give parenteral fluids as prescribed. Adequate blood volume sustains cardiac output and systemic perfusion.

13. Give heparin as prescribed. Anticoagulation prevents new clots by slowing the clotting mechanism.

3. Preventing Bleeding and Injury

The clotting system burns through coagulation factors faster than the body can replace them, so clotting ability collapses and bleeding climbs. Heparin adds to that risk when factors are already depleted. Monitor coagulation parameters, replace blood products, and manage every invasive site carefully.

1. Assess for the underlying cause. DIC is never the primary disease; it follows a trigger such as infection or tumor. Treating that disorder is the core of treatment.

2. Assess heart rate and blood pressure; watch for orthostatic hypotension. Tachycardia and hypotension signal decreased cardiac output. Orthostasis (a drop of more than 15 mm Hg from supine to sitting) signals reduced circulating volume.

3. Watch for internal bleeding (pain, changes in level of consciousness) and run a neurological checklist. A changing level of consciousness can come from decreased volume or falling hemoglobin.

4. Watch for external bleeding from the GI and GU tracts. A diagnostic hallmark of acute DIC is bleeding from at least 3 unrelated sites alongside shock, respiratory failure, or renal failure. Look for skin bruising, hemoptysis, and hematuria.

5. Note hemoptysis or blood from suctioning. Both are common in acute DIC.

6. Examine the skin for bleeding. Note petechiae, purpura, hematomas, oozing from IV sites, drains, and wounds, and mucous membrane bleeding. Prolonged oozing from injection or venipuncture sites can be the first sign of DIC.

7. Monitor hemoglobin and hematocrit. Falling values track with bleeding from DIC.

8. Monitor serial coagulation profiles. Clotting accelerates first. As it drives the fibrinolytic system, factors deplete and fibrin degradation products pour out. Common DIC values: PT greater than 15 seconds, PTT greater than 60 to 90 seconds, hypofibrinogenemia, thrombocytopenia, elevated fibrin split products (FSPs), elevated D-dimers, and prolonged bleeding time. Specific deficiencies guide therapy.

9. If heparin is running, watch for increased bleeding (IV sites, GI/GU, respiratory tract, wounds) and new purpura, petechiae, or hematoma. Heparin suits milder cases where clotting outweighs bleeding; it blocks thrombin production to abort the clotting process.

10. Run precautionary measures. Avoid intramuscular injections and unnecessary venipunctures, draw labs through an existing arterial or venous heparin lock line, and apply pressure to oozing sites. IM injections cause bleeding and hematomas, which in DIC feed further clotting and organ damage. Use oral or subcutaneous routes instead.

11. Give gentle oral care with saline and water rinses instead of a toothbrush. Oral care prevents infection, but brushing risks bleeding; rinses do the job without it.

12. Use gentle chest physiotherapy. Turning, repositioning, coughing, deep breathing, percussion, and vibration, all done gently to limit bleeding and tissue injury.

13. Give heparin as prescribed, titrated to labs and clinical picture. Heparin boosts antithrombin III activity, interrupting the clotting cycle and the conversion of fibrinogen to fibrin, and inhibits factor X to slow clot formation. As the picture improves, the heparin need drops. If bleeding increases, notify the physician about decreasing the IV drip. The hard part is telling heparin-related blood loss apart from worsening DIC.

14. Give parenteral fluids as prescribed; anticipate an IV fluid challenge for hypotension. Adequate blood volume sustains cardiac output and systemic perfusion.

15. Give blood products as prescribed: red blood cells (RBCs), fresh frozen plasma (FFP), cryoprecipitate, and platelets. RBCs raise oxygen-carrying capacity, FFP replaces clotting factors and inhibitors, and platelets and cryoprecipitate supply proteins for coagulation.

16. Give additional or investigational medications as ordered. See Pharmacologic Management.

4. Patient Education

DIC usually hits acutely, so the patient and family start with no background. Teach the causes and risk factors, the signs of bleeding and clotting, why each medication matters, and what to report.

1. Assess the client's knowledge of DIC. The acute onset means little prior knowledge; the assessment sets a teaching baseline.

2. Explain the cause that precipitated DIC. Basic information helps the client and family ask the right questions.

3. Explain the purpose of drug and transfusion therapy. The treatment can be hard to follow in an acute setting, and frequent blood components may raise fears about transmitting hepatitis or HIV.

4. Tell the client and family to report new bleeding from wounds or IV sites. This drives early intervention. Expect new bleeding to be frightening for them.

5. Monitoring for Complications

1. Monitor vital signs regularly. Blood pressure, heart rate, respiratory rate, and temperature flag complications early so you can intervene before further deterioration.

2. Monitor cardiac rhythm. Continuous rhythm and ECG monitoring catches arrhythmias and changes in cardiac function.

3. Assess neurological status. Level of consciousness, motor strength, and sensory function reveal compromised cerebral perfusion.

4. Assess respiratory status. Respiratory rate, oxygen saturation, and lung sounds flag distress or compromised gas exchange.

5. Assess bleeding and clotting tendencies. Watch for petechiae, purpura, hematuria, and signs of clot formation.

6. Monitor laboratory studies. Complete blood counts, coagulation profiles, and renal and hepatic function tests track organ function and guide treatment.

7. Monitor fluid balance. Intake, output, and hydration status confirm adequate perfusion and catch hypovolemia or overload.

8. Monitor the medication regimen for side effects and interactions. Anticoagulants and blood products carry real risks and need close watching.

9. Collaborate with the interdisciplinary team. Physicians, pharmacists, and lab staff round out assessment and monitoring and improve outcomes.

10. Educate the patient and family on complications. Cover the signs to watch for, the need to report changes promptly, and followup appointments.

6. Medications and Pharmacologic Support

Drug therapy in DIC targets the underlying cause, manages complications, and restores hemostatic balance. Watch closely for side effects and interactions and reassess the response.

1. Heparin. An anticoagulant that prevents new and progressing clots by inhibiting clotting factors and fibrin formation.

2. Antithrombin III concentrate. A heparin cofactor for more severe cases. Its anti-inflammatory properties help when sepsis is the trigger. Antithrombin III inhibits thrombin and factor Xa to limit excess clotting.

3. Epsilon-aminocaproic acid (Amicar). An antifibrinolytic reserved for when other measures fail. It blocks plasmin to stop clot breakdown. Use is controversial because it can cause organ failure from large-vessel thrombosis.

4. Hirudin. A thrombin inhibitor used when heparin is contraindicated or ineffective. Clinical experience with it is limited.

5. Recombinant human-activated protein C. Inhibits factors Va and VIIIa of the coagulation cascade.

6. Platelet transfusions. Raise the platelet count and improve clotting in severe thrombocytopenia.

7. Fresh frozen plasma (FFP). Replaces the range of clotting factors in patients with coagulation abnormalities.

8. Cryoprecipitate. Supplies concentrated fibrinogen, von Willebrand factor, and other clotting factors to manage severe bleeding.

7. Monitoring Laboratory and Diagnostic Procedures

These tests track whether DIC is progressing or resolving, guide treatment, and gauge the response to therapy.

1. Complete blood count (CBC). Shows platelet count, red cell count, and white cell count, marking the severity of thrombocytopenia and anemia.

2. Coagulation profiles. PT, activated partial thromboplastin time (aPTT), and INR evaluate clotting ability; abnormal results point to DIC.

3. Fibrinogen level. Fibrinogen is a key clotting factor, and its level reflects clotting capacity and disease course.

4. D-dimer assay. A fibrin degradation product. Elevated levels show ongoing fibrinolysis; serial measurements track the response to treatment.

5. Liver and renal function tests. DIC hits the liver and kidneys. Monitor liver enzymes (ALT, AST) and renal function (serum creatinine) for organ involvement.

6. Imaging studies. Ultrasound, CT, or MRI evaluate organ damage or identify thrombus formation.

7. Arterial blood gas analysis. ABGs assess acid-base balance and oxygenation, reflecting respiratory function and tissue perfusion.